To check the efficacy of mepivacaine as supplemental intraligamentary injection after failed inferior alveolar nerve block in symptomatic irreversible pulpitis paients
Phase 4
- Conditions
- Health Condition 1: K040- Pulpitis
- Registration Number
- CTRI/2023/08/056538
- Lead Sponsor
- Susmita Ghosh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients are in good health, patients should have symptomatic irreversible pulpitis in one of their mandibular molars, patients can understand heft-parker visual analogue scale, patients able to sign informed consent.
Exclusion Criteria
Administration of analgesics within 12 hr before taking study drug, allergies to aceclofenac, mepivacaine or articaine or sulphites, pregnant or lactating women, patients with introral lesion at the site of injection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anaesthetic efficacy & pain reduction would be assessed using Heft-Parker Visual Analogue Scale.Timepoint: It will be assessed at pre-opearatively, after inferior alveolar nerve block, access into dentin, and access into pulp chamber.
- Secondary Outcome Measures
Name Time Method o secondary outcomeTimepoint: .